Yes, P3 has started, and you can see that two P3 (Coast and Shore) trials have now been fully subscribed. Take a look back at the OPT forum; you'll find plenty of high IQ medical types discussing this, eg https://hotcopper.com.au/threads/ann-opthea-completes-enrollment-in-phase-3-clinical-program.8023197/
By earliest this time next year, topline results should be known, or it could end up around Aug/Sep 2025.
In my opinion, OPT is either a zero bagger or a 10X —there's not much in between. IMHO, it is the best risk-reward stock on the ASX, but my eyes are open to the very real reality of a potential full loss of capital.
Ann: Trading Halt, page-22
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.010(2.78%) |
Mkt cap ! $382.0M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 36.5¢ | 35.0¢ | $934.4K | 2.624M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 230715 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 17816 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| OPT (ASX) Chart |